Drug Database
Back to search

Belgium· BE-AMP-SAM538284-00

Dengvaxia

A dengue-virus-impfstoffe product containing dengue virus, tetravalent, live, attenuated, registered in Belgium by Sanofi Winthrop Industrie. The same ATC class is registered in 10 of our 19 countries.

ATC J07BX04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDengvaxiaATCJ07BX04REGISTER NO.BE-AMP-SAM538284-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dengue virus, tetravalent, live, attenuatedAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dengue-virus-impfstoffe is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BX04 (dengue-virus-impfstoffe), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search dengue-virus-impfstoffe products by name

Dengue-virus-impfstoffe · ATC J07BX04

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Dengue Virus, Tetravalent, Live, Attenuated
Manufacturer
Sanofi Winthrop Industrie
Country
Belgium (BE)
ATC code
J07BX04
ATC class
Dengue-Virus-Impfstoffe
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BX04

Dengue-virus-impfstoffe, as other registers publish it.

All dengue-virus-impfstoffe products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1c646edb-6d1a-4188-9fa4-b49400919816
GET /v1/drugs/1c646edb-6d1a-4188-9fa4-b49400919816?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for suspension for injection in pre-filled syringe",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Dengvaxia",
  "name_fr": "Dengvaxia",
  "name_nl": "Dengvaxia",
  "amp_code": "SAM538284-00",
  "strengths": null,
  "pack_count": 4,
  "substances": [
    "Dengue Virus, Tetravalent, Live, Attenuated",
    "Sodium Chloride",
    "Sorbitol",
    "Sucrose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Dengue Virus Vaccines",
  "authorisation_numbers": [
    "EU/1/18/1338/001",
    "EU/1/18/1338/003",
    "EU/1/18/1338/002",
    "EU/1/18/1338/004"
  ]
}
API referenceMCP serverPlans

See everything about dengue-virus-impfstoffe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console